Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
HiPass Design is a private healthcare technology company focused on nighttime movement monitoring for people with epilepsy and other conditions requiring careful overnight observation. The company is best known for SAMi, a touchless sleep activity monitor that uses infrared video-based motion detection to detect, record, and alert caregivers to abnormal movements during sleep. Its products are aimed primarily at home monitoring rather than therapeutic drug development, positioning the company more as a medical device and digital health business than a biotech or pharma company. HiPass Design has been active for more than a decade and has worked closely with epilepsy-focused organizations to commercialize and improve its monitoring solution.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HiPass Design.